Katarzyna Stencel

Lodz, LD, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Efficacy and safety of first-line immune checkpoint inhibitors in patients with PD-L1 <1% metastatic non-small-cell lung cancer - implications for daily clinical practice.

Efficacy and safety of first-line immune checkpoint inhibitors in patients with PD-L1 <1% metastatic non-small-cell lung cancer - implications for daily clinical practice.

Journal: Expert review of anticancer therapy

Published: September 15, 2025

Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib.

Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib.

Journal: Clinical lung cancer

Published: August 19, 2025

Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.

Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.

Journal: Lancet (London, England)

Published: April 01, 2025

Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review.

Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review.

Journal: Translational lung cancer research

Published: March 17, 2024

Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study.

Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study.

Journal: Cancers

Published: December 15, 2023

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice.

Journal: Frontiers in oncology

Published: November 19, 2023

Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy.

Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy.

Journal: EXCLI journal

Published: April 21, 2023

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer-Clinical Trials Experience.

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer-Clinical Trials Experience.

Journal: Cancers

Published: August 07, 2021

Non-Small-Cell Lung Cancer: New Rare Targets-New Targeted Therapies-State of The Art and Future Directions.

Non-Small-Cell Lung Cancer: New Rare Targets-New Targeted Therapies-State of The Art and Future Directions.

Journal: Cancers

Published: February 06, 2021

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.

Journal: International journal of molecular sciences

Published: December 03, 2020

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.

Journal: Oncology letters

Published: November 04, 2020

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

Journal: Oncology letters

Published: February 24, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026